Advanced Healthcare Materials · 2022 · 76 citations · 31 references
MedicineBiomedical SciencesPharmacologyBiomaterialsDrug DeliveryTargeted Drug DeliveryAngiogenesisBiomaterials For Tissue EngineeringNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignAngiogenic BiomaterialsDiabetic Wound HealingDiabetic Wound RepairExosome UptakeExosome-based TherapyExtrusionInduced Pluripotent Stem CellsWound Healing Angiogenesis
Angiogenesis plays a critical role in diabetic wound healing. However, no effective strategies have been developed to target endothelial cells (ECs) to facilitate diabetic wound healing. Dapagliflozin (DA) as a sodium-glucose linked transporter 2 (SGLT2) inhibitor, may promote neovascularization in diabetic mice via HIF-1α-mediated enhancement of angiogenesis. Here, the bioinspired nanovesicles (NVs) prepared from induced pluripotent stem cells-derived ECs through an extrusion approach are reported, which can function as exosome mimetics to achieve targeted deliver of DA. Abundant membrane C-X-C motif chemokine receptor 4 conferred the EC-targeting ability of these NVs and the endothelial homology facilitated the accumulation in ECs. Furthermore, these DA-loaded induced pluripotent stem cells (iPSC)-EC NVs can facilitate angiogenesis and diabetic wound healing by HIF-1α/VEGFA pathway. Taken together, this study indicated that targeting ECs and regulating angiogenesis may be a promising strategy for the treatment of diabetic wound healing.
31
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez‐Erviti, Yiqi Seow, HaiFang Yin et al. · Nature Biotechnology · 2011 · 4.8K citations
Jan Lötvall, Andrew F. Hill, Fred H. Hochberg et al. · Journal of Extracellular Vesicles · 2014 · 2.7K citations · Full text
Su Chul Jang, Oh Youn Kim, Chang Min Yoon et al. · ACS Nano · 2013 · 1K citations
Pharmacy, Oncology, Pharmacology +17